Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akihiro Kitadate

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 1, 2025
[Treatment strategies for multiple myeloma based on molecular biology and cytogenetic abnormalities]Akihiro Kitadate
International Journal of Hematology|April 2, 2024
Optimizing random skin biopsies: a review of techniques and indications for intravascular large B-cell lymphomaNaoko Enzan, Akihiro Kitadate, Michihiro Kono
International Journal of Hematology|July 20, 2022
High baseline total lesion glycolysis predicts early progression of disease within 24 months in patients with high-tumor-burden follicular lymphomaWataru Kuroki, Akihiro Kitadate, Koichi Ishiyama, et al.
Blood Advances|February 16, 2018
Hypoxia-inducible KDM3A addiction in multiple myelomaSho Ikeda, Akihiro Kitadate, Fumito Abe, et al.
Internal Medicine (Tokyo, Japan)|April 29, 2025
Successful Salvage Therapy with Pomalidomide, Cyclophosphamide, and Dexamethasone for IgM Myeloma with t(11;14) and Dim CD38 Expression Refractory to Daratumumab, Lenalidomide, and DexamethasoneTakashi Fujishima, Takahiro Kobayashi, Isuzu Kobayashi, et al.
Mycoses|June 6, 2019
Higher frequency of false-positive serum galactomannan tests among older subjects and the association with elevated serum immunoglobulin G levelsYoshiaki Abe, Kentaro Narita, Hiroki Kobayashi, et al.
Cancer Science|August 14, 2020
Hypoxia-inducible hexokinase-2 enhances anti-apoptotic function via activating autophagy in multiple myelomaSho Ikeda, Fumito Abe, Yuka Matsuda, et al.
Cancer Medicine|February 13, 2023
Hypoxia-induced oxidative stress promotes therapy resistance via upregulation of heme oxygenase-1 in multiple myelomaKo Abe, Sho Ikeda, Miho Nara, et al.
Clinical Nuclear Medicine|December 14, 2019
18F-FDG PET/CT-Guided Diagnosis and Evaluation of Treatment Response to Cyclosporine A in Maldistributed Subcutaneous Panniculitis-like T-Cell Lymphoma Without Typical Skin RashYoshiaki Abe, Kentaro Narita, Hiroki Kobayashi, et al.
Japanese Journal of Clinical Oncology|January 5, 2019
Prevalence and clinical implications of t(11;14) in patients with amyloid light-chain amyloidosis with or without concurrent multiple myelomaHiroki Kobayashi, Yoshiaki Abe, Daisuke Miura, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 1, 2025
[Treatment strategies for multiple myeloma based on molecular biology and cytogenetic abnormalities]Akihiro Kitadate
International Journal of Hematology|April 2, 2024
Optimizing random skin biopsies: a review of techniques and indications for intravascular large B-cell lymphomaNaoko Enzan, Akihiro Kitadate, Michihiro Kono
International Journal of Hematology|July 20, 2022
High baseline total lesion glycolysis predicts early progression of disease within 24 months in patients with high-tumor-burden follicular lymphomaWataru Kuroki, Akihiro Kitadate, Koichi Ishiyama, et al.
Blood Advances|February 16, 2018
Hypoxia-inducible KDM3A addiction in multiple myelomaSho Ikeda, Akihiro Kitadate, Fumito Abe, et al.
Internal Medicine (Tokyo, Japan)|April 29, 2025
Successful Salvage Therapy with Pomalidomide, Cyclophosphamide, and Dexamethasone for IgM Myeloma with t(11;14) and Dim CD38 Expression Refractory to Daratumumab, Lenalidomide, and DexamethasoneTakashi Fujishima, Takahiro Kobayashi, Isuzu Kobayashi, et al.
Mycoses|June 6, 2019
Higher frequency of false-positive serum galactomannan tests among older subjects and the association with elevated serum immunoglobulin G levelsYoshiaki Abe, Kentaro Narita, Hiroki Kobayashi, et al.
Cancer Science|August 14, 2020
Hypoxia-inducible hexokinase-2 enhances anti-apoptotic function via activating autophagy in multiple myelomaSho Ikeda, Fumito Abe, Yuka Matsuda, et al.
Cancer Medicine|February 13, 2023
Hypoxia-induced oxidative stress promotes therapy resistance via upregulation of heme oxygenase-1 in multiple myelomaKo Abe, Sho Ikeda, Miho Nara, et al.
Clinical Nuclear Medicine|December 14, 2019
18F-FDG PET/CT-Guided Diagnosis and Evaluation of Treatment Response to Cyclosporine A in Maldistributed Subcutaneous Panniculitis-like T-Cell Lymphoma Without Typical Skin RashYoshiaki Abe, Kentaro Narita, Hiroki Kobayashi, et al.
Japanese Journal of Clinical Oncology|January 5, 2019
Prevalence and clinical implications of t(11;14) in patients with amyloid light-chain amyloidosis with or without concurrent multiple myelomaHiroki Kobayashi, Yoshiaki Abe, Daisuke Miura, et al.
Pageof 5